The Pharmaceutical Research and Manufacturers of America (PhRMA) is combining forces with two other groups to challenge the FDA final rule allowing broad, state-by-state importation of drugs from Canada.

The Centers for Medicare and Medicaid Services recently issued what it called a "historic" update in a bid to "unleash innovation" in medicine. 

The Hoover Institution fellow and White House COVID-19 advisor drew fire earlier this week for urging Michigan residents to stand up against further lockdowns. 

Reduced access to mammography and other services may "exacerbate already significant disparities," Chief Research Officer Etta Pisano, MD, said.

The neuroradiologist and fellow of Stanford’s Hoover Institution labeled fellow coronavirus counselor Anthony Fauci a "political animal" in a recent interview. 

President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?  

A healthcare research firm specializing in purchasing has considered the post-election landscape from the vantage point of large employers offering health benefits to their workers.

CMS is proposing to close the so-called “valley of death” between FDA approval of imaging products and Medicare payment authorization.